Impact of the COVID-19 pandemic on HIV care in Guatemala. (July 2021)
- Record Type:
- Journal Article
- Title:
- Impact of the COVID-19 pandemic on HIV care in Guatemala. (July 2021)
- Main Title:
- Impact of the COVID-19 pandemic on HIV care in Guatemala
- Authors:
- Medina, Narda
Alastruey-Izquierdo, Ana
Bonilla, Oscar
Ortíz, Brenan
Gamboa, Osmar
Salazar, Luis Roberto
Mercado, Danicela
Pérez, Juan C.
Denning, David W.
Arathoon, Eduardo
Rodriguez-Tudela, Juan Luis
Pérez, Oscar Eduardo López
Barrientos, Brenan Ortiz
Muñoz, Vilma Alejandrina Reyes
Aguilar, Gladys Sajché
Andrade, Aura Marina Méndez
Marina de León, Luis Roberto Santa
Alcázar, Ana Lucía Gómez
González, Eduardo Celada
Quiñónez M, Gustavo A.
Sontay, Germán Orlando Cuyuch
Marín, Alba Virtud Contreras
de Lourdes Fong Araujo, María
Guzmán, Brenda - Abstract:
- Highlights: The COVID-19 pandemic has disrupted healthcare services. In Guatemala, the COVID-19 pandemic has severely impacted human immunodeficiency (HIV) services. During the COVID-19 pandemic, deaths due to opportunistic infections increased by 10.7%. HIV testing decreased by 54.7% during the COVID-19 pandemic. Abstract: Objectives: To describe the impact of the coronavirus disease 2019 (COVID-19) pandemic on the diagnosis of human immunodeficiency virus (HIV) and deaths from opportunistic infections in Guatemala. Methods: A retrospective study was conducted to investigate the impact of the COVID-19 pandemic on people with HIV at a referral clinic (Clinica Familiar Luis Angel García, CFLAG), as well as the disruption of services at a diagnostic laboratory hub (DLH) which provides diagnosis for opportunistic infections to a network of 13 HIV healthcare facilities. Comparative analysis was undertaken using the months March–August from two different time periods: (i) pre-COVID-19 (2017–2019); and (ii) during the COVID-19 period (2020). Results: During the COVID-19 period, 7360 HIV tests were performed at Clinica Familiar Luis Angel García, compared with an average of 16, 218 tests in the pre-COVID-19 period; a reduction of 54.7% [95% confidence interval (CI) 53.8–55.4%], Deaths from opportunistic infections at 90 days were 10.7% higher in 2020 compared with 2019 (27.3% vs 16.6%; P = 0.05). Clinical samples sent to the DLH for diagnosis of opportunistic infections decreasedHighlights: The COVID-19 pandemic has disrupted healthcare services. In Guatemala, the COVID-19 pandemic has severely impacted human immunodeficiency (HIV) services. During the COVID-19 pandemic, deaths due to opportunistic infections increased by 10.7%. HIV testing decreased by 54.7% during the COVID-19 pandemic. Abstract: Objectives: To describe the impact of the coronavirus disease 2019 (COVID-19) pandemic on the diagnosis of human immunodeficiency virus (HIV) and deaths from opportunistic infections in Guatemala. Methods: A retrospective study was conducted to investigate the impact of the COVID-19 pandemic on people with HIV at a referral clinic (Clinica Familiar Luis Angel García, CFLAG), as well as the disruption of services at a diagnostic laboratory hub (DLH) which provides diagnosis for opportunistic infections to a network of 13 HIV healthcare facilities. Comparative analysis was undertaken using the months March–August from two different time periods: (i) pre-COVID-19 (2017–2019); and (ii) during the COVID-19 period (2020). Results: During the COVID-19 period, 7360 HIV tests were performed at Clinica Familiar Luis Angel García, compared with an average of 16, 218 tests in the pre-COVID-19 period; a reduction of 54.7% [95% confidence interval (CI) 53.8–55.4%], Deaths from opportunistic infections at 90 days were 10.7% higher in 2020 compared with 2019 (27.3% vs 16.6%; P = 0.05). Clinical samples sent to the DLH for diagnosis of opportunistic infections decreased by 43.7% in 2020 (95% CI 41.0–46.2%). Conclusion: The COVID-19 pandemic is having a substantial impact on HIV care in Guatemala. Diagnostic services for HIV have been severely affected and deaths from opportunistic infections have increased. The lessons learnt must guide the introduction of strategies to reduce the impact of the pandemic. … (more)
- Is Part Of:
- International journal of infectious diseases. Volume 108(2021)
- Journal:
- International journal of infectious diseases
- Issue:
- Volume 108(2021)
- Issue Display:
- Volume 108, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 108
- Issue:
- 2021
- Issue Sort Value:
- 2021-0108-2021-0000
- Page Start:
- 422
- Page End:
- 427
- Publication Date:
- 2021-07
- Subjects:
- COVID-19 -- HIV testing -- Opportunistic infections -- Healthcare attention
Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
Electronic journals
616.9 - Journal URLs:
- http://bibpurl.oclc.org/web/73769 ↗
http://www.journals.elsevier.com/international-journal-of-infectious-diseases/ ↗
http://www.sciencedirect.com/science/journal/12019712 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/12019712 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/12019712 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijid.2021.06.011 ↗
- Languages:
- English
- ISSNs:
- 1201-9712
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.304750
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18302.xml